References
- Raccuglia G. Gray platelet syndrome. A variety of qualitative platelet disorder. Am J Med 1971; 51: 818–828
- Schmitt A, Jouault H, Guichard J, Wendling F, Drouin A, Cramer EM. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. Blood 2000; 96: 1342–1347
- Smith MP, Cramer EM, Savidge GF. Megakaryocytes and platelets in alpha-granule disorders. Baillieres Clin Haematol 1997; 10: 125–148
- Jantunen E, Hanninen A, Naukkarinen A, Vornanen M, Lahtinen R. Gray platelet syndrome with splenomegaly and signs of extramedullary hematopoiesis: A case report with review of the literature. Am J Hematol 1994; 46: 218–224
- Cramer EM, Vainchenker W, Vinci G, Guichard J, Breton-Gorius J. Gray platelet syndrome: Immunoelectron microscopic localization of fibrinogen and von Willebrand factor in platelets and megakaryocytes. Blood 1985; 66: 1309–1316
- Rosa JP, George JN, Bainton DF, Nurden AT, Caen JP, McEver RP. Gray platelet syndrome.Demonstration of alpha granule membranes that can fuse with the cell surface. J Clin Invest 1987; 80: 1138–1146
- Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev 1993; 7: 52–62
- Harrison P, Savidge GF, Cramer EM. The origin and physiological relevance of alpha-granule adhesive proteins. Br J Haematol 1990; 74: 125–130
- Drouin A, Favier R, Masse JM, Debili N, Schmitt A, Elbim C, Guichard J, Adam M, Gougerot-Pocidalo MA, Cramer EM. Newly recognized cellular abnormalities in the gray platelet syndrome. Blood 2001; 98: 1382–1391
- White JG, Brunning RD. Neutrophils in the gray platelet syndrome. Platelets 2004; 15: 333–340
- Falik-Zaccai TC, Anikster Y, Rivera CE, Horne MK, 3rd, Schliamser L, Phornphutkul C, Attias D, Hyman T, White JG, Gahl WA. A new genetic isolate of gray platelet syndrome (GPS): Clinical, cellular, and hematologic characteristics. Mol Genet Metab 2001; 74: 303–313